The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.

MLA

Thakar, Monica S., et al. “The Hematopoietic Cell Transplant Comorbidity Index Predicts Survival after Allogeneic Transplant for Nonmalignant Diseases.” Blood, vol. 133, no. 7, Feb. 2019, pp. 754–62. EBSCOhost, https://doi.org/10.1182/blood-2018-09-876284.

APA

Thakar, M. S., Broglie, L., Logan, B., Artz, A., Bunin, N., Burroughs, L. M., Fretham, C., Jacobsohn, D. A., Loren, A. W., Kurtzberg, J., Martinez, C. A., Mineishi, S., Nelson, A. S., Woolfrey, A., Pasquini, M. C., & Sorror, M. L. (2019). The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood, 133(7), 754–762. https://doi.org/10.1182/blood-2018-09-876284

Chicago

Thakar, Monica S, Larisa Broglie, Brent Logan, Andrew Artz, Nancy Bunin, Lauri M Burroughs, Caitrin Fretham, et al. 2019. “The Hematopoietic Cell Transplant Comorbidity Index Predicts Survival after Allogeneic Transplant for Nonmalignant Diseases.” Blood 133 (7): 754–62. doi:10.1182/blood-2018-09-876284.